PIPERAZINE DERIVATIVES FOR TREATMENT OF AD AND RELATED CONDITIONS
申请人:Blurton Peter
公开号:US20100204230A1
公开(公告)日:2010-08-12
Compounds of formula (I) selectively inhibit production of Aβ(1-42) and hence find use in treatment of Alzheimer's disease and other conditions associated with deposition of A(β) in the brain.